trial
as of 2026-07-01Melatonin Treatment for Tardive Dyskinesia in Schizophrenia
NCTId NCT01391390
at a glance
— · Completed
Enrollment 120 (actual)
Sponsored by Beijing HuiLongGuan Hospital
Primary completion 2011-04
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
120 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2008-09
Primary completion
2011-04
Eligibility
ALL · 18 Years · 70 Years
Interventions & indications
Drugs
Sponsors
Beijing HuiLongGuan HospitalLead Sponsor
Stanley Medical Research InstituteCollaborator
Investigators
1
Lian Y Cao, MDStudy Chair
Sites
1 total
Beijing, China
Facts & assertions
4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2011-04
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
collaborator
indication
investigator
person